Special Drug Use-results Surveillance of Tabrecta Tablets

Clinical trial NCT04575025 · COMPLETED

Trial details

NCT number: NCT04575025
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2020-11-02
Primary completion: 2024-10-26
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.